Dược phẩm 2 News →

DBD

Dược - Trang thiết bị y tế Bình Định

50,200
+0.20%
Mkt Cap 945.3B
Data as of 2026-06-05 · Source: public Vietnamese market feeds

DBD is a Vietnam-listed stock for Dược - Trang thiết bị y tế Bình Định in the Dược phẩm sector. The latest tracked close is 50,200 VND, +0.20% on the session. Aveluro has analyzed 3 Vietnamese financial news articles mentioning DBD, with positive as the dominant sentiment; the latest catalyst is strategic partnership: Bidiphar (DBD) Launches Large-Scale Digital Transformation with SAP S/4HANA.

What matters now

Latest price
50,200 VND · +0.20%
Dominant Sentiment
Positive · 3 Articles Analyzed
Latest catalyst
strategic partnership
Liquidity
Low
Data as of
2026-06-05

Bidiphar (DBD) Launches Large-Scale Digital Transformation with SAP S/4HANA

Caveat: Not investment advice. · How Aveluro computed this: Aveluro combines extracted event facts, source credibility, ticker context, and market data. Scores are deterministic research signals, not recommendations.

5.8
Hold
Sentiment
+0.00
Impact
0.50
Momentum
-0.31
Fundamentals
+0.00
Volume
0.00

Want to trade DBD? Compare brokers for Vietnam stocks.

Foreign investors need a broker that can handle Vietnam market access, settlement, custody, and foreign ownership limits.

Compare brokers

Aveluro may earn a commission from broker partners. Market data and broker availability can change; confirm access before opening an account.

Price Chart
Liquidity
10-Session Avg Vol
41.4K
Today's Volume
12.4K
vs Avg
0.30×
Market Cap
₫945.3B
Liquidity
Low

Low liquidity — thin average daily volume may result in wider spreads and price impact on larger orders.

News Sentiment
Articles Analyzed
3
Dominant Sentiment
Positive
Positive 2
Neutral 1
Recent News
Full Analysis strategic partnership May 13, 2026
Bidiphar (DBD) Launches Large-Scale Digital Transformation with SAP S/4HANA

DBD partners with Citek to launch a comprehensive digital transformation project, upgrading to SAP S/4HANA Private Cloud and implementing CSV, IFRS, and BI systems. This initiative aims to standardize operations, enhance transparency, and meet international pharmaceutical standards, positioning DBD for sustainable growth.

5 +5.0 Positive
Read full analysis →
Full Analysis capital raise Apr 17, 2026
Bidiphar (DBD) Plans VND 1,165B Private Placement for Two Pharma Factories

Bidiphar (DBD) will propose a private placement of 23.3 million shares to raise approximately VND 1,165 billion at a minimum price of VND 50,000 per share, targeting up to five professional investors. The capital is earmarked to fund two key pharmaceutical factory projects with a combined budget of VND 1,710 billion, as the company seeks to expand its production capacity following a year of revenue shortfall against plan.

6 Neutral
Read full analysis →
Apr 10, 2026
4 Positive
Related Stocks — Dược phẩm
DCL Dược phẩm Cửu Long stock analysis DHG Dược Hậu Giang stock analysis DMC Xuất nhập khẩu Y tế Domesco stock analysis IMP Dược phẩm Imexpharm stock analysis LDP Dược Lâm Đồng - Ladophar stock analysis MED Dược Trung ương Mediplantex stock analysis TRA Traphaco stock analysis
Stock Analysis
DBD stock news Vietnam Dashboard Vietnam stocks for foreigners Foreign ownership limits

Information provided for educational purposes only. Past performance does not guarantee future results. Data sourced from public Vietnamese market feeds.

Last updated: 2026-06-05T19:15:56Z.

About · Methodology · Privacy